Overview

Workgroup for the Prescription Drug Pricing Program Pursuant to Section 340B of the federal Public Health Service Act

Pursuant to section 16 of Connecticut Public Act 23-171, on January 31, 2024, the Department of Social Services submitted this report regarding the Prescription Drug Pricing Program Pursuant to Section 340B of the federal Public Health Service Act; an updated appendix to the report is posted here.

Section 340B of the federal Public Health Service Act established the 340B Drug Pricing Program, which is administered by the U.S. Department of Health and Human Services (HHS), Health Resources and Services Administration (HRSA), Office of Pharmacy Affairs (OPA).  For general information regarding the 340B program, please visit the HRSA website at this link: https://www.hrsa.gov/opa.  Under state law in section 16 of Public Act 23-171, the Department of Social Services is required to convene a working group to evaluate “(1) the current status of the federal 340B drug pricing program authorized by 42 USC 256b, as amended from time to time, (2) national efforts to strengthen and sustain such program, and (3) opportunities for state action to protect 340B revenues of federally qualified health centers from unfair administrative barriers or unnecessary conditions based on such centers' status as a 340B covered entity.”

For any questions about this workgroup, please email: Public.Comment.DSS@ct.gov or write to: Department of Social Services, Commissioner’s Office, Policy Division, 55 Farmington Avenue, Hartford, CT 06105.